Perinatal adverse effects of nalbuphine given during parturition.
Guillonneau
M
M
Jacqz-Aigrain
E
E
de Crepy
A
A
Zeggout
H
H
D000328:Adult; D000698:Analgesia; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007279:Injections, Subcutaneous; D007749:Labor Stage, Third / Q000187:drug effects*; D007743:Labor, Obstetric / Q000187:drug effects*; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D009019:Morphinans / Q000009:adverse effects*; D009266:Nalbuphine / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000139:chemically induced*
D009019:Morphinans; D009266:Nalbuphine